Paragon 28, Inc. (NYSE:FNA) Holdings Trimmed by HighMark Wealth Management LLC

HighMark Wealth Management LLC lessened its position in Paragon 28, Inc. (NYSE:FNA) by 1.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 512,144 shares of the company’s stock after selling 6,001 shares during the period. Paragon 28 makes up 3.0% of HighMark Wealth Management LLC’s investment portfolio, making the stock its 6th largest holding. HighMark Wealth Management LLC owned 0.61% of Paragon 28 worth $5,290,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in FNA. Barclays PLC raised its holdings in Paragon 28 by 180.6% during the third quarter. Barclays PLC now owns 84,812 shares of the company’s stock worth $567,000 after purchasing an additional 54,591 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Paragon 28 by 2,141.7% in the third quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock valued at $5,243,000 after buying an additional 749,865 shares in the last quarter. GSA Capital Partners LLP acquired a new position in shares of Paragon 28 during the 3rd quarter worth $386,000. Ballentine Partners LLC raised its stake in shares of Paragon 28 by 15.0% during the 4th quarter. Ballentine Partners LLC now owns 15,630 shares of the company’s stock worth $161,000 after buying an additional 2,043 shares during the last quarter. Finally, State Street Corp boosted its position in shares of Paragon 28 by 2.6% in the 3rd quarter. State Street Corp now owns 1,563,331 shares of the company’s stock worth $10,443,000 after buying an additional 39,075 shares in the last quarter. 63.57% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, major shareholder Mvm Partners, Llc sold 4,256 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $10.00, for a total transaction of $42,560.00. Following the completion of the sale, the insider now owns 10,499,960 shares in the company, valued at approximately $104,999,600. The trade was a 0.04 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In the last ninety days, insiders have sold 300,192 shares of company stock valued at $3,135,086. 15.32% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Needham & Company LLC reiterated a “hold” rating and issued a $13.00 price target on shares of Paragon 28 in a research report on Wednesday, January 29th. William Blair cut Paragon 28 from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. Canaccord Genuity Group restated a “hold” rating on shares of Paragon 28 in a research report on Wednesday, January 29th. Finally, Stephens reaffirmed an “equal weight” rating and set a $13.00 price objective (down previously from $14.00) on shares of Paragon 28 in a research note on Thursday, January 30th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Paragon 28 presently has a consensus rating of “Hold” and an average target price of $14.60.

Paragon 28 Stock Performance

NYSE:FNA opened at $13.06 on Tuesday. Paragon 28, Inc. has a fifty-two week low of $4.65 and a fifty-two week high of $14.78. The firm’s 50 day moving average is $11.24 and its two-hundred day moving average is $8.78. The company has a market cap of $1.09 billion, a P/E ratio of -17.64 and a beta of 1.54. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.